| # | Drug | Count |
|---|---|---|
| 0 | DARBEPOETIN ALFA | 994 |
| 1 | FUROSEMIDE | 599 |
| 2 | ASPIRIN | 482 |
| 3 | ASPIRIN 325 MG | 477 |
| 4 | ASPIRIN 81 MG | 477 |
| 5 | OMEPRAZOLE MAGNESIUM | 440 |
| 6 | METFORMIN | 426 |
| 7 | METFORMIN HCL | 382 |
| 8 | LANSOPRAZOLE | 348 |
| 9 | OMEPRAZOLE | 318 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VANCOMYCIN HYDROCHLORIDE | 249 | 0.0298 |
| 1 | 3% SODIUM CHLORIDE | 3 | 0.0263 |
| 2 | DOXERCALCIFEROL | 4 | 0.0240 |
| 3 | FOMEPIZOLE | 4 | 0.0212 |
| 4 | GADODIAMIDE | 65 | 0.0193 |
| 5 | DARBEPOETIN ALFA | 994 | 0.0184 |
| 6 | ALUMINUM HYDROXIDE GEL | 2 | 0.0136 |
| 7 | SODIUM NITROPRUSSIDE | 5 | 0.0129 |
| 8 | ACAMPROSATE CALCIUM | 4 | 0.0120 |
| 9 | GLUCARPIDASE | 4 | 0.0110 |
| # | Drug class | Count |
|---|---|---|
| 0 | Erythropoiesis-stimulating Agent [EPC] | 994 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 915 |
| 2 | Corticosteroid [EPC] | 759 |
| 3 | Loop Diuretic [EPC] | 664 |
| 4 | Proton Pump Inhibitor [EPC] | 602 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 494 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 460 |
| 7 | Benzodiazepine [EPC] | 375 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 359 |
| 9 | beta-Adrenergic Blocker [EPC] | 346 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Erythropoiesis-stimulating Agent [EPC] | 994 | 0.0184 |
| 1 | Paramagnetic Contrast Agent [EPC] | 65 | 0.0141 |
| 2 | Lead Chelator [EPC] | 1 | 0.0119 |
| 3 | Carboxypeptidase [EPC] | 4 | 0.0110 |
| 4 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 5 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 13 | 0.0057 |
| 6 | Vitamin D2 Analog [EPC] | 40 | 0.0056 |
| 7 | CD33-directed Immunoconjugate [EPC] | 20 | 0.0055 |
| 8 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 2 | 0.0051 |
| 9 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 42 | 0.0043 |